0001918188-22-000001.txt : 20220411 0001918188-22-000001.hdr.sgml : 20220411 20220408194304 ACCESSION NUMBER: 0001918188-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20220411 DATE AS OF CHANGE: 20220408 EFFECTIVENESS DATE: 20220411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Prevounce Health, Inc. CENTRAL INDEX KEY: 0001918188 IRS NUMBER: 880602300 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-441204 FILM NUMBER: 22818272 BUSINESS ADDRESS: STREET 1: 3250 N POST ROAD, SUITE 180 CITY: INDIANAPOLIS STATE: IN ZIP: 46226 BUSINESS PHONE: 800-618-7738 MAIL ADDRESS: STREET 1: 3250 N POST ROAD, SUITE 180 CITY: INDIANAPOLIS STATE: IN ZIP: 46226 D 1 primary_doc.xml X0708 D LIVE 0001918188 Prevounce Health, Inc. 3250 N POST ROAD, SUITE 180 INDIANAPOLIS IN INDIANA 46226 800-618-7738 DELAWARE Prevounce Health, LLC None Corporation true 2020 Daniel Tashnek 3250 N Post Road, Suite 180 Indianapolis IN INDIANA 46226 Executive Officer Director Gary Tashnek 3250 N Post Road, Suite 180 Indianapolis IN INDIANA 46226 Director Michael Kluger 3250 N Post Road, Suite 180 Indianapolis IN INDIANA 46226 Director Michael Hammond 3250 N Post Road, Suite 180 Indianapolis IN INDIANA 46226 Director Stephen Hanson 3250 N Post Road, Suite 180 Indianapolis IN INDIANA 46226 Director Timothy J. Hargarten 3250 N Post Road, Suite 180 Indianapolis IN INDIANA 46226 Director Other Technology Decline to Disclose 06c false 2022-03-28 false true false 100000 4500000 4500000 0 false 10 0 0 150000 true Issuer borrowed from Gary Tashnek, a director and stockholder of Issuer, the total sum of $150,000, pursuant to promissory notes. As disclosed to investors, Issuer agreed to pay off the notes (including interest thereon) following closing of the offering. false Prevounce Health, Inc. Daniel Tashnek Daniel Tashnek President 2022-04-08